DELAYED MORTALITY AFTER MID-LETHAL EXPOSURES TO WHOLE-BODY IRRADIATION AND ITS MODIFICATION BY TREATMENT WITH SYNGENEIC LYMPH-NODE OR BONE-MARROW CELLS.
Journal Article
·
· Int. J. Radiat. Biol., 11: 409-27(1966).
- Research Organization:
- Medical Research Council, Harwell, Eng.
- Sponsoring Organization:
- USDOE
- NSA Number:
- NSA-21-020306
- OSTI ID:
- 4449553
- Journal Information:
- Int. J. Radiat. Biol., 11: 409-27(1966)., Other Information: Orig. Receipt Date: 31-DEC-67
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Similar Records
SURVIVAL OF CALVES TREATED WITH AUTOLOGOUS BONE MARROW AFTER EXPOSURE TO LETHAL DOSE OF WHOLE-BODY IRRADIATION
TREATMENT OF MOUSE LYMPHOSARCOMA BY TOTAL-BODY IRRADIATION AND BY INJECTION OF BONE MARROW AND LYMPH-NODE CELLS
16,16-Dimethyl prostaglandin E2 and/or syngeneic bone marrow transplantation increase mouse survival after supra-lethal total body irradiation
Journal Article
·
Tue Nov 01 00:00:00 EST 1960
· Proc. Soc. Exptl. Biol. Med.
·
OSTI ID:4449553
+3 more
TREATMENT OF MOUSE LYMPHOSARCOMA BY TOTAL-BODY IRRADIATION AND BY INJECTION OF BONE MARROW AND LYMPH-NODE CELLS
Journal Article
·
Mon Dec 01 00:00:00 EST 1958
· Journal of the National Cancer Institute (U.S.) Changed to JNCI, J. Natl. Cancer Inst.
·
OSTI ID:4449553
16,16-Dimethyl prostaglandin E2 and/or syngeneic bone marrow transplantation increase mouse survival after supra-lethal total body irradiation
Journal Article
·
Fri Jun 01 00:00:00 EDT 1990
· International Journal of Radiation Oncology, Biology and Physics; (USA)
·
OSTI ID:4449553